Literature DB >> 15518050

Myasthenia gravis.

Angela Vincent1, Peter Rothwell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15518050     DOI： 10.1080/08916930410001708751

Source DB:  PubMed          Journal:  Autoimmunity        ISSN： 0891-6934            Impact factor:   2.815


× No keyword cloud information.
  7 in total

1.  Experimental autoimmune myasthenia gravis in the mouse.

Authors:  B Wu; E Goluszko; P Christadoss
Journal:  Curr Protoc Immunol       Date:  2001-05

Review 2.  Future perspectives in target-specific immunotherapies of myasthenia gravis.

Authors:  Marinos C Dalakas
Journal:  Ther Adv Neurol Disord       Date:  2015-11       Impact factor: 6.570

Review 3.  Immunotherapy in myasthenia gravis in the era of biologics.

Authors:  Marinos C Dalakas
Journal:  Nat Rev Neurol       Date:  2019-02       Impact factor: 42.937

4.  Hashimoto's encephalopathy cases: Chinese experience.

Authors:  Yi Tang; Yi Xing; Michael T Lin; Jin Zhang; Jianping Jia
Journal:  BMC Neurol       Date:  2012-07-24       Impact factor: 2.474

Review 5.  Pathogenesis of myasthenia gravis: update on disease types, models, and mechanisms.

Authors:  William D Phillips; Angela Vincent
Journal:  F1000Res       Date:  2016-06-27

Review 6.  Immunopathology of Autoimmune Myasthenia Gravis: Implications for Improved Testing Algorithms and Treatment Strategies.

Authors:  Hans Frykman; Pankaj Kumar; Joel Oger
Journal:  Front Neurol       Date:  2020-12-09       Impact factor: 4.003

7.  Gut bacterial microbiota in patients with myasthenia gravis: results from the MYBIOM study.

Authors:  Andreas Totzeck; Elakiya Ramakrishnan; Melina Schlag; Benjamin Stolte; Kathrin Kizina; Saskia Bolz; Andreas Thimm; Mark Stettner; Julian R Marchesi; Jan Buer; Christoph Kleinschnitz; Hedda Luise Verhasselt; Tim Hagenacker
Journal:  Ther Adv Neurol Disord       Date:  2021-08-11       Impact factor: 6.570
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.